JP2022512647A5 - - Google Patents
Info
- Publication number
- JP2022512647A5 JP2022512647A5 JP2021519612A JP2021519612A JP2022512647A5 JP 2022512647 A5 JP2022512647 A5 JP 2022512647A5 JP 2021519612 A JP2021519612 A JP 2021519612A JP 2021519612 A JP2021519612 A JP 2021519612A JP 2022512647 A5 JP2022512647 A5 JP 2022512647A5
- Authority
- JP
- Japan
- Prior art keywords
- aureus
- antigen
- antibody
- binding fragment
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862743490P | 2018-10-09 | 2018-10-09 | |
| US62/743,490 | 2018-10-09 | ||
| US201962833297P | 2019-04-12 | 2019-04-12 | |
| US62/833,297 | 2019-04-12 | ||
| PCT/US2019/055143 WO2020076789A2 (en) | 2018-10-09 | 2019-10-08 | Combinations of anti-staphylococcus aureus antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512647A JP2022512647A (ja) | 2022-02-07 |
| JP2022512647A5 true JP2022512647A5 (enExample) | 2022-10-18 |
Family
ID=70051346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519612A Ceased JP2022512647A (ja) | 2018-10-09 | 2019-10-08 | 抗黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）抗体の組み合わせ |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11168133B2 (enExample) |
| EP (1) | EP3864041A2 (enExample) |
| JP (1) | JP2022512647A (enExample) |
| KR (1) | KR20210072057A (enExample) |
| CN (1) | CN113164602A (enExample) |
| AU (1) | AU2019357983A1 (enExample) |
| BR (1) | BR112021006622A2 (enExample) |
| CA (1) | CA3115633A1 (enExample) |
| MX (1) | MX2021004173A (enExample) |
| TW (1) | TW202035443A (enExample) |
| WO (1) | WO2020076789A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015010125A2 (pt) * | 2012-11-06 | 2017-08-22 | Medimmune Llc | Anticorpo isolado ou seu fragmento de ligação, composição, ácido nucleico isolado, métodos de determinação da presença de s. aureus em uma amostra de teste, de tratamento de uma infecção por s. aureus em um paciente, de prevenção ou redução da gravidade de sepsia associada a s. aureus em um paciente, de atraso do início de sepsia associada a infecção por s. aureus em um paciente, de prevenção do início de sepsia associada a infecção por s. aureus em um paciente, de redução de carga bacteriana de s. aureus na corrente sanguínea ou coração em um paciente, e de redução da aglutinação bacteriana de s. aureus e/ou formação de lesões tromboembólicas em um paciente |
| JP7525471B2 (ja) | 2018-07-24 | 2024-07-30 | メディミューン，エルエルシー | Ｓ．アウレウス（Ｓ．ａｕｒｅｕｓ）クランピング因子Ａ（ＣｌｆＡ）に対する抗体 |
| TWI895248B (zh) | 2018-10-09 | 2025-09-01 | 美商麥迪紐有限責任公司 | 針對金黃色葡萄球菌白血球毒素的抗體 |
| BR112021006622A2 (pt) | 2018-10-09 | 2021-07-20 | Medimmune, Llc | combinações de anticorpos anti-staphylococcus aureus |
| CN113811544A (zh) | 2019-03-13 | 2021-12-17 | 免疫医疗有限责任公司 | 减少定殖患者中的金黄色葡萄球菌感染 |
| CN115989235A (zh) * | 2020-05-07 | 2023-04-18 | 普利安特治疗公司 | 使用氨基酸化合物治疗呼吸系统疾病的方法 |
| CN117771379B (zh) * | 2023-10-25 | 2024-08-30 | 珠海泰诺麦博制药股份有限公司 | 特异性结合金黄色葡萄球菌Hla毒素的全人源抗体与抗生素的组合 |
| CN121537524B (zh) * | 2026-01-20 | 2026-04-28 | 江西省人民医院 | 一种mda5人源化单克隆抗体及其制备方法和应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US7658921B2 (en) | 2000-12-12 | 2010-02-09 | Medimmune, Llc | Molecules with extended half-lives, compositions and uses thereof |
| PT1377314E (pt) | 2001-01-26 | 2012-01-02 | Inhibitex Inc | Anticorpos monoclonais para a proteína clfa e método de utilização no tratamento ou prevenção de infecções |
| MXPA05000511A (es) | 2001-07-12 | 2005-09-30 | Jefferson Foote | Anticuepros super humanizados. |
| US20030226155A1 (en) | 2001-08-30 | 2003-12-04 | Biorexis Pharmaceutical Corporation | Modified transferrin-antibody fusion proteins |
| US20040014194A1 (en) | 2002-03-27 | 2004-01-22 | Schering Corporation | Beta-secretase crystals and methods for preparing and using the same |
| ATE458006T1 (de) | 2003-05-14 | 2010-03-15 | Kenta Biotech Ag | Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa |
| CN1324049C (zh) | 2003-08-04 | 2007-07-04 | 中国疾病预防控制中心病毒病预防控制所 | 人源抗sars冠状病毒基因工程抗体 |
| PT1737891E (pt) | 2004-04-13 | 2013-04-16 | Hoffmann La Roche | Anticorpos anti p-selectina |
| TW200813091A (en) | 2006-04-10 | 2008-03-16 | Amgen Fremont Inc | Targeted binding agents directed to uPAR and uses thereof |
| US20080131457A1 (en) | 2006-06-12 | 2008-06-05 | Nabi Biopharmaceuticals | Use of alpha-toxin for treating and preventing staphylococcus infections |
| US20090075378A1 (en) | 2007-02-20 | 2009-03-19 | Anaptysbio, Inc. | Somatic hypermutation systems |
| PL2188313T3 (pl) | 2007-08-21 | 2018-04-30 | Amgen, Inc. | Białka wiążące ludzki antygen c-fms |
| JP5658564B2 (ja) | 2007-08-31 | 2015-01-28 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物 |
| JP2011526792A (ja) | 2008-07-02 | 2011-10-20 | エマージェント プロダクト デベロップメント シアトル， エルエルシー | ＴＮＦ−αアンタゴニスト多重標的結合性タンパク質 |
| EP2208787A1 (en) | 2009-01-19 | 2010-07-21 | Université de Liège | A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| CN104119438A (zh) | 2009-01-29 | 2014-10-29 | 米迪缪尼有限公司 | 延长体内半衰期的人抗il-6抗体及其在治疗肿瘤、自身免疫性疾病和炎症性疾病中的应用 |
| EP4015523A1 (en) | 2010-05-05 | 2022-06-22 | New York University | Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| PT2673373T (pt) | 2011-02-08 | 2018-12-05 | Medimmune Llc | Anticorpos que ligam especificamente a toxina alfa de staphylococcus aureus e métodos de utilização |
| KR20210083389A (ko) | 2012-11-06 | 2021-07-06 | 메디뮨 엘엘씨 | 에스.아우레우스 연관 질병의 치료 방법 |
| BR112015010125A2 (pt) | 2012-11-06 | 2017-08-22 | Medimmune Llc | Anticorpo isolado ou seu fragmento de ligação, composição, ácido nucleico isolado, métodos de determinação da presença de s. aureus em uma amostra de teste, de tratamento de uma infecção por s. aureus em um paciente, de prevenção ou redução da gravidade de sepsia associada a s. aureus em um paciente, de atraso do início de sepsia associada a infecção por s. aureus em um paciente, de prevenção do início de sepsia associada a infecção por s. aureus em um paciente, de redução de carga bacteriana de s. aureus na corrente sanguínea ou coração em um paciente, e de redução da aglutinação bacteriana de s. aureus e/ou formação de lesões tromboembólicas em um paciente |
| RU2016119052A3 (en) | 2013-10-17 | 2018-09-10 | Arsanis Biosciences Gmbh | Cross-reactive Staphylococcus aureus antibody sequences |
| ES2869459T3 (es) | 2014-05-16 | 2021-10-25 | Medimmune Llc | Moléculas con unión a receptor de fc de neonato alterada que tiene propiedades terapéuticas y de diagnóstico potenciadas |
| TWI719938B (zh) | 2014-06-19 | 2021-03-01 | 美商麥迪紐有限責任公司 | 多重細菌感染之治療 |
| CN107873034A (zh) * | 2015-04-17 | 2018-04-03 | 阿尔萨尼斯生物科学有限责任公司 | 抗金黄色葡萄球菌抗体组合制剂 |
| WO2017075188A2 (en) | 2015-10-30 | 2017-05-04 | Medimmune, Llc | Methods of using anti-alpha toxin antibody |
| JP7525471B2 (ja) | 2018-07-24 | 2024-07-30 | メディミューン，エルエルシー | Ｓ．アウレウス（Ｓ．ａｕｒｅｕｓ）クランピング因子Ａ（ＣｌｆＡ）に対する抗体 |
| BR112021006622A2 (pt) | 2018-10-09 | 2021-07-20 | Medimmune, Llc | combinações de anticorpos anti-staphylococcus aureus |
| TWI895248B (zh) | 2018-10-09 | 2025-09-01 | 美商麥迪紐有限責任公司 | 針對金黃色葡萄球菌白血球毒素的抗體 |
-
2019
- 2019-10-08 BR BR112021006622-5A patent/BR112021006622A2/pt not_active IP Right Cessation
- 2019-10-08 AU AU2019357983A patent/AU2019357983A1/en not_active Abandoned
- 2019-10-08 TW TW108136341A patent/TW202035443A/zh unknown
- 2019-10-08 EP EP19871705.0A patent/EP3864041A2/en not_active Withdrawn
- 2019-10-08 US US16/596,388 patent/US11168133B2/en active Active
- 2019-10-08 WO PCT/US2019/055143 patent/WO2020076789A2/en not_active Ceased
- 2019-10-08 MX MX2021004173A patent/MX2021004173A/es unknown
- 2019-10-08 JP JP2021519612A patent/JP2022512647A/ja not_active Ceased
- 2019-10-08 KR KR1020217013653A patent/KR20210072057A/ko not_active Ceased
- 2019-10-08 CN CN201980078574.1A patent/CN113164602A/zh active Pending
- 2019-10-08 CA CA3115633A patent/CA3115633A1/en active Pending
-
2021
- 2021-10-01 US US17/491,889 patent/US20220089699A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512647A5 (enExample) | ||
| US12428473B2 (en) | Combination therapies using anti-pseudomonas PSL and PCRV binding molecules | |
| US8653242B2 (en) | Therapeutic antibodies against flagellated Pseudomonas aeruginosa | |
| CN101910197B (zh) | 针对铜绿假单胞菌pcrv抗原的抗体 | |
| JP2022105178A (ja) | 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染症を治療および予防するための組成物および方法 | |
| US20150284450A1 (en) | Combination therapies using anti-pseudomonas psl and pcrv binding molecules | |
| JP2022512646A5 (enExample) | ||
| KR20100021577A (ko) | 에스.아우레우스 ＯＲＦ0657ｎ을 표적화하는 항원 결합 단백질 | |
| EP1720908A2 (en) | Super-humanized antibodies against respiratory syncytial virus | |
| JP2019505527A5 (enExample) | ||
| US8617548B2 (en) | Methods of preventing or treating anthrax using anti-anthrax antibodies | |
| JP2021530244A5 (enExample) | ||
| JP2013508292A5 (enExample) | ||
| JP2016501877A5 (enExample) | ||
| US20170183397A1 (en) | Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereof | |
| JP2023537078A5 (enExample) | ||
| JP2024535124A5 (enExample) | ||
| WO2022148480A1 (zh) | 靶向金黄色葡萄球菌α-毒素的抗原结合蛋白及其应用 | |
| EP3224279B1 (en) | Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the il-20r. | |
| JP2022548881A5 (enExample) | ||
| RU2817697C1 (ru) | Моноклональное антитело iC2 и его антигенсвязывающий фрагмент, селективно связывающие рецептор-связывающий домен Spike-белка вируса SARS-CoV-2, обладающие вируснейтрализующей активностью | |
| RU2021112346A (ru) | Комбинации антител к staphylococcus aureus | |
| WO2024248127A1 (ja) | アレルギー疾患予防・治療薬 | |
| WO2022140659A2 (en) | Anti-cd47 antibodies and uses thereof | |
| NZ624072B2 (en) | Combination therapies using anti- pseudomonas psl and pcrv binding molecules |